Plain-English translation of NCT07354126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different medications— and —to see which one works better at preventing migraines in children. Both medications are already used by doctors to prevent migraines, but doctors don't have clear evidence about which one works best or is easiest to use. This study will help answer that question.
Doctors prescribe both of these medications for migraine prevention in children, but there hasn't been much research directly comparing them. By finding out which medication works better and is safer, doctors will have better information to choose the right treatment for each child.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either or by mouth for 3 months. The dose would start low and gradually increase over the first few weeks. During this time, you'd have regular follow-up visits so the doctor can check how well the medication is working and watch for any side effects. You'd also track your migraines using a special scoring system to measure whether your headaches improve.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Pakistan
Sponsor
Muhammad Aamir Latif
Enrollment target
~44 participants
Started
September 2025
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
8 Years – 15 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ishafaq Ahmed, FCPS
The Children's Hospital Lahore
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.